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955Unlike a new drug therapy, a procedural or surgical innovation
is likely dependent on the skill and experience of the physi-
cians performing the technique. Accordingly, the Consoli-
dated Standards of ReportingTrials (CONSORT) guidelines
recommend that all randomized trials of nonpharmacological
interventions collect data and perform analyses based on
procedural volume (1).
Greater percutaneous coronary intervention (PCI) proce-
dural volume has been linked to improved clinical outcomes in
studies reporting primarily femoral access (2,3). These data
have led to the American College of Cardiology, American
Heart Association, and Society of Cardiac Angiography and
Intervention guidelines recommending a minimum of 75 PCI
procedures per year for an interventional cardiologist to
enhance patient safety (4). However, radial access is technically
more challenging and may have a longer learning curve and
require higher volumes to achieve andmaintain proﬁciency (5).
With rapidly increasing use of radial access, it is important to
understand the relationship between procedural volume and
outcomes with this technique.
See page 973
The RIVAL (RadIal Vs. femorAL) trial randomized
7,021 patients with acute coronary syndromes (ACS) to
radial versus femoral access for coronary angiography and
intervention (6,7). The trial showed no difference between
radial and femoral access for the primary outcome of death,
myocardial infarction (MI), stroke, or non–coronary artery
bypass graft surgery (CABG)–related major bleeding, but
radial access was associated with a statistically signiﬁcant
63% reduction in major vascular complications. In the
subgroup of high-volume radial centers the primary outcome
was reduced by radial versus femoral access, but it was not
reduced in intermediate- or low-volume radial centers.
There was no signiﬁcant interaction by individual operator
radial volume.
The objective of the present analyses is to explore in
greater depth the interaction between procedural volumes
and access site for various outcomes in the RIVAL trial.
Methods
Study design. The design of the RIVAL trial has been
previously published (6). It was a prospective randomized
trial among patients with acute coronary syndromes
comparing radial versus femoral access for coronary angi-
ography and same sitting PCI if clinically indicated.
Between June 6, 2006, and November 3, 2010, 7,021
patients were enrolled from 158 hospitals in 32 countries.
Patients were eligible for the study if: 1) they presentedwith
non–ST-segment or ST-segment elevation ACS; 2) they
were to be managed with an invasive approach; 3) the inter-
ventional cardiologist was willing to proceed with either radial
or femoral approach (and had expertise with both, including atleast 50 radial procedures within
the previous year); and 4) the
patient had intact dual circulation
of the hand documented by
Allen’s test. Patients were not
eligible if they presented with
cardiogenic shock, had severe
peripheral vascular disease pre-
cluding a femoral approach, or
had prior coronary bypass surgery
with use of more than 1 internal
mammary artery.
The primary outcome was the
composite of death, MI, stroke, or
non–CABG-related major bleed-
ing. Each center was required to
report the number of overall, radial,
and femoral procedures per year
for participating operators. At each center, the median operator
volume for a center was calculated and used to classify center
volume because overall center volume was not collected.
Statistical analyses. Centers were divided into tertiles
according to the median radial PCI volume of their opera-
tors: (low [60 radial PCI/year/operator], intermediate
[61 to 146 radial PCI/year/operator], and high [>146 radial
PCI/year/operator]). The tertile analysis for center and
operator volume was pre-speciﬁed.
Baseline characteristics and cointerventions were docu-
mented for the tertiles of low-, intermediate-, and high-
volume radial centers (Table 1). The hazard ratios of radial
versus femoral access for the primary outcome and secondary
outcomes were compared within these tertiles.
ST-segment elevation MI and center volume. High-
volume radial centers enrolled signiﬁcantly higher propor-
tion of ST-segment elevation myocardial infarction
(STEMI). Interactions were observed with beneﬁt of radial
access in both STEMI subgroup and high-volume radial
centers. As a result, an adjusted analysis was performed using
the diagnosis of STEMI prior to randomization in a Cox
proportional hazards model to help determine the inde-
pendent effect of volume apart from STEMI (8).
For operator-level data instead of center-level analyses,
operators were divided into tertiles according to individual
operator radial PCI volume: (low [70 radial PCI/year/
operator], intermediate [71 to 142 radial PCI/year/oper-
ator], high [>142 radial PCI/year/operator]). The hazard
ratios (HRs) for the primary and secondary outcomes were
compared within these tertiles. Finally, for both center
and operator tertiles, stratiﬁed analyses for STEMI and
non–ST-segment elevation acute coronary syndromes
(NSTEACS) were performed.
All analyses were by intention to treat, unless otherwise
speciﬁed. For subgroup analyses, HRs and 95% conﬁdence
intervals (CIs) and interaction p values were calculated.
Statistical interactions were evaluated at a signiﬁcance level
of 0.05 with no adjustment made for multiple comparisons.
Table 1 Baseline Characteristics for Low-, Intermediate-, and High-Tertile Radial Centers
Lowest Tertile
(n ¼ 1,920)
Intermediate Tertile
(n ¼ 2,846)
Highest Tertile
(n ¼ 2,255) p Value
Mean age, yrs 61.3  11.06 62.5  12.2 61.2  11.5 <0.001
Age >75 yrs, % 226 (11.8) 511 (18.0) 298 (13.2) <0.001
Male, % 1,458 (75.9) 2,040 (71.7) 1,662 (73.7) 0.005
Killip class 2, % 75 (3.9) 136 (4.8) 136 (6.0) 0.006
Admission diagnosis
NSTEACS 1,488 (77.8) 2,215 (77.5) 1,360 (60.3) <0.001
STEMI 432 (22.5) 631 (22.2) 895 (39.7) <0.001
Prior history
Diabetes 467 (24.3) 578 (20.3) 458 (20.3) 0.001
Myocardial infarction 342 (17.8) 528 (18.6) 410 (18.2) 0.81
PCI 211 (11.0) 325 (11.4) 303 (13.4) 0.028
CABG surgery 23 (1.2) 95 (3.3) 36 (1.6) <0.001
ECG and biomarkers in NSTEACS
ST-segment depression 521 (35.0) 769 (34.7) 567 (41.7) 0.002
Biomarker positive 937 (63.0) 1,592 (71.9) 670 (49.3) <0.001
Therapies during initial hospitalization
Aspirin 1,911 (99.5) 2,820 (99.1) 2,237 (99.2) 0.21
Clopidogrel 1,815 (94.5) 2,746 (96.5) 2,165 (96.0) 0.004
Statin 1,857 (96.7) 2,636 (92.6) 2,105 (93.3) <0.001
ACE inhibitor 1,497 (78.0) 1,943 (68.3) 1,645 (72.9) <0.001
Glycoprotein IIb/IIIa inhibitor 566 (29.5) 715 (25.1) 450 (20.0) <0.001
Bivalirudin 24 (1.3) 91 (3.2) 70 (3.1) <0.001
Interventions during initial hospitalization
PCI 1,257 (65.5) 1,708 (60.0) 1,695 (75.2) <0.001
CABG surgery 160 (8.3) 364 (12.8) 75 (3.3) <0.001
Intra-aortic balloon pump 11 (0.6) 35 (1.2) 22 (1.0) 0.08
Procedural details
Diagnostic catheters used
1 338 (17.6) 550 (19.4) 706 (31.4) <0.001
2 984 (51.3) 1,620 (57.1) 1,273 (56.6) <0.001
3 588 (30.7) 654 (23.0) 258 (11.5) <0.001
PCI guide catheters used
1 1,030 (81.9) 1,421 (83.2) 1,409 (83.1) 0.62
2 165 (13.1) 201 (11.8) 232 (13.7) 0.23
3 60 (4.8) 79 (4.6) 49 (2.9) 0.011
Values are mean  SD or n (%).
ACE ¼ angiotensin-converting enzyme; CABG ¼ coronary artery bypass graft; ECG ¼ electrocardiography; NSTEACS ¼ non–ST-segment elevation
acute coronary syndrome(s); PCI ¼ percutaneous coronary intervention; STEMI ¼ ST-segment elevation myocardial infarction.
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956Observational multivariable analyses of volume and
outcome. A multivariable analysis with a Cox proportional
hazards model was performed to determine if overall (radial
and femoral) center PCI volume (per 50 PCI/year for
center’s median operator volume) was independently
associated with the primary outcome, mortality, and non-
CABG major bleeding after adjusting for age, sex, dia-
betes, prior PCI, creatinine, systolic blood pressure and
heart rate at presentation, STEMI, elevated biomarker
at presentation, Killip class, in-hospital PCI, in-hospital
coronary bypass surgery, glycoprotein IIb/IIIa inhibitor
therapy, and enrollment during the CURRENT (Clopi-
dogrel and Aspirin Optimal Usage to Reduce Recurrent
evenTs) trial or after.
A similar analysis was repeated for radial PCI center
volumes for patients randomized to radial access and femoralPCI center volumes for patients randomized to femoral
access. Finally, this analysis was repeated at the individual
operator level for overall operator PCI volume, radial volume,
and femoral volume. The same variables for operator-level
analysis were used as for center analysis in the Cox propor-
tional hazards model.
All statistical analyses were performed using SAS version
9.1 (SAS Institute Inc., Cary, North Carolina).
Results
The baseline characteristics of patients enrolled from low-,
intermediate-, and high-volume radial centers are shown
in Table 1. High-volume centers were more likely to
enroll STEMI patients and patients with Killip class 2
heart failure at presentation. High-volume radial centers
Figure 1
Randomization to End of PCI in Patients Undergoing
Primary PCI
Randomization to end of percutaneous coronary intervention (PCI) (min) in patients
undergoing primary PCI in low-, intermediate-, and high-volume radial centers.
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957had higher PCI rates, perhaps explained by their hig-
her proportion of subjects with STEMI. Intermediate-
volume radial centers randomized a higher proportion of
elderly patients (age >75 years) with biomarker-positive
NSTEACS. Lower-volume radial centers tended to use
more diagnostic catheters and were more likely to use 3 or
more PCI guide catheters during a procedure.
Among patients undergoing primary PCI, door-
to-balloon times were not collected, but the time from
randomization to completion of PCI was longer in radial
than femoral procedures in low- (65 min vs. 52 min;
p < 0.001) and intermediate-volume centers (72 min vs.
60 min; p ¼ 0.011), but was not signiﬁcantly different inTable 2
Characteristics of Tertiles of Radial Cen
Femoral Center and Operator
Low Tertile
Radial center*
Radial PCI procedures 39 (24–60)
Femoral PCI procedures 151 (102–300)
Total PCI procedures 200 (150–360)
% Radial 20
Femoral center*
Radial PCI procedures 170 (80–570)
Femoral PCI procedures 30 (20–70)
Total PCI procedures 240 (145–600)
% Radial 80
Radial operator
Radial PCI procedures 39 (24–58)
Femoral PCI procedures 145 (104–258)
Total PCI procedures 196 (150–300)
% Radial 20
Femoral operator
Radial PCI procedures 152 (80–340)
Femoral PCI procedures 40 (20–72)
Total PCI procedures 200 (144–400)
% Radial 80
Values are median (interquartile range). *Center volumes are represented b
PCI ¼ percutaneous coronary intervention.high-volume radial centers (55 min vs. 51 min; p ¼ 0.78)
(Fig. 1). Low-volume radial centers performed 20% of PCI
procedures per year via radial access, whereas high-volume
centers performed 75% (Table 2).
Radial versus femoral access in subgroups of center
volume (low, intermediate, and high). For the primary
outcome, a beneﬁt was observed for radial versus femoral
access in the highest-volume radial centers (1.6% vs. 3.2%;
HR: 0.49, 95% CI: 0.28 to 0.87) but not in intermediate-
(5.4% vs. 4.4%; HR: 1.23, 95% CI: 0.88 to 1.72) or low-
volume radial centers (3.4% vs. 4.2%; HR: 0.83, 95% CI:
0.52 to 1.31; interaction p ¼ 0.021) (Table 3).
For the composite of death, MI, or stroke, a beneﬁt was
observed for radial versus femoral access in the highest-
volume radial centers (1.3% vs. 2.7%; HR: 0.50, 95% CI:
0.27 to 0.92) but not in intermediate- (4.9% vs. 3.6%; HR:
1.38, 95% CI: 0.96 to 1.98) or low-volume radial centers
(2.8% vs. 3.4%; HR: 0.82, 95% CI: 0.49 to 1.36; interaction
p ¼ 0.013) (Table 3).
Among the subgroups of high-, intermediate-, and low-
volume radial centers, there were no differences in the
outcome of non-CABG major bleeding using the RIVAL
deﬁnition for radial versus femoral access (Table 3). How-
ever, for ACUITY (Acute Catheterization and Urgent
Intervention Triage strategY) trial non-CABG major
bleeding, the largest reductions with radial access occurred
at high-volume radial centers (HR: 0.23, 95% CI: 0.12 to
0.43) compared with intermediate- (HR: 0.59, 95% CI:
0.40 to 0.87) and low-volume radial centers (HR: 0.41,
95% CI: 0.21 to 0.77; interaction p ¼ 0.037). The lowest
access site crossover from radial to femoral was observed inter and Operator and
Middle Tertile High Tertile
100 (73–135) 240 (168–432)
165 (110–210) 75 (30–180)
250 (190–350) 400 (300–600)
40 75
80 (43–135) 100 (59–150)
128 (100–165) 245 (175–360)
220 (154–300) 350 (287–506)
40 30
105 (80–135) 240 (180–432)
165 (80–180) 89 (30–180)
250 (199–300) 446 (300–600)
40 75
80 (50–135) 100 (39–150)
140 (114–165) 280 (225–402)
250 (180–300) 400 (350–600)
40 25
y median operator volume for participating operators at a center.
Table 3 Radial Versus Femoral Access by Radial PCI Center Volume
Radial
(n ¼ 3,507)
Femoral
(n ¼ 3,514) HR (95% CI) p Value
Interaction
p Value
Primary outcome
High-volume center 18 (1.6) 36 (3.2) 0.49 (0.28–0.87) 0.015 0.021
Intermediate-volume center 77 (5.4) 63 (4.4) 1.23 (0.88–1.72) 0.22
Low-volume center 33 (3.4) 40 (4.2) 0.83 (0.52–1.31) 0.42
Death, MI, or stroke
High-volume center 15 (1.3) 30 (2.7) 0.50 (0.27–0.92) 0.027 0.013
Intermediate-volume center 70 (4.9) 51 (3.6) 1.38 (0.96–1.98) 0.078
Low-volume center 27 (2.8) 33 (3.4) 0.82 (0.49–1.36) 0.45
Death
High-volume center 9 (0.8) 17 (1.5) 0.53 (0.23–1.18) 0.12 0.26
Intermediate-volume center 23 (1.6) 19 (1.3) 1.22 (0.66–2.23) 0.53
Low-volume center 12 (1.2) 15 (1.6) 0.80 (0.38–1.72) 0.57
MI
High-volume center 6 (0.5) 13 (1.2) 0.46 (0.17–1.20) 0.11 0.19
Intermediate-volume center 40 (2.8) 34 (2.4) 1.18 (0.75–1.87) 0.47
Low-volume center 14 (1.5) 18 (1.9) 0.78 (0.39–1.56) 0.48
Stroke
High-volume center 3 (0.3) 3 (0.3) 1.00 (0.20–4.95) 1.00 0.88
Intermediate-volume center 12 (0.9) 8 (0.6) 1.50 (0.61–3.68) 0.37
Low-volume center 5 (0.5) 3 (0.3) 1.68 (0.40–7.04) 0.48
Non-CABG major bleeding
High-volume center 5 (0.4) 11 (1.0) 0.45 (0.16–1.30) 0.14 0.54
Intermediate-volume center 11 (0.8) 14 (1.0) 0.79 (0.36–1.73) 0.55
Low-volume center 8 (0.8) 8 (0.8) 1.00 (0.38–2.68) 0.99
ACUITY major bleeding
High-volume center 12 (1.1) 52 (4.6) 0.23 (0.12–0.43) <0.001 0.037
Intermediate-volume center 41 (2.9) 69 (4.9) 0.59 (0.40–0.87) 0.008
Low-volume center 13 (1.4) 32 (3.3) 0.41 (0.21–0.77) 0.006
Major vascular complications
High-volume center 8 (0.7) 45 (4.0) 0.18 (0.08–0.37) <0.001 0.019
Intermediate-volume center 33 (2.3) 58 (4.1) 0.57 (0.37–0.87) 0.010
Low-volume center 8 (0.8) 28 (2.9) 0.29 (0.13–0.63) 0.002
Access site crossover
High-volume center 50 (4.4) 26 (2.3) 1.92 (1.19–3.08) 0.007 0.003
Intermediate-volume center 138 (9.7) 33 (2.3) 4.22 (2.89–6.18) <0.001
Low-volume center 77 (8.0) 11 (1.1) 7.13 (3.79–13.40) <0.001
PCI success rates
High-volume center 820 (96.3) 798 (94.7) 1.03 (0.93–1.14) 0.56 0.70
Intermediate-volume center 786 (93.9) 829 (95.3) 0.97 (0.88–1.07) 0.58
Low-volume center 598 (96.3) 608 (95.7) 1.02 (0.91–1.14) 0.75
PCI complications
High-volume center 18 (2.1) 22 (2.6) 0.81 (0.43–1.50) 0.50 0.89
Intermediate-volume center 32 (3.8) 34 (3.9) 0.98 (0.60–1.58) 0.92
Low-volume center 10 (1.6) 12 (1.9) 0.85 (0.37–1.98) 0.71
Values are n (%). At high-volume centers 2,255 patients were enrolled, in intermediate-volume centers 2,846 patients were enrolled, and at low-
volume centers 1,920 patients were enrolled.
ACUITY ¼ Acute Catheterization and Urgent Intervention Triage strategY; CI ¼ conﬁdence interval; HR ¼ hazard ratio; other abbreviation as in
Table 1.
Jolly et al. JACC Vol. 63, No. 10, 2014
Procedural Volume and Radial Versus Femoral Access March 18, 2014:954–63
958highest-volume radial centers (HR: 1.92, 95% CI: 1.19 to
3.08) compared with intermediate- (HR: 4.22, 95% CI: 2.89
to 6.18) and low-volume radial centers (HR: 7.13, 95% CI:
3.79 to 13.40; interaction p ¼ 0.003).
There were no differences in PCI success rates or angio-
graphic complications between radial and femoral access
across the subgroups of high, intermediate, and low radial
center volume (Table 3).Femoral outcomes in different radial tertiles. To deter-
mine if the beneﬁt of radial access in high-volume radial
centers was due to poorer outcomes in femoral patients, we
performed an adjusted analysis comparing patients ran-
domized to femoral access between low- and high-volume
radial sites using variables listed in the Methods section.
There were no signiﬁcant differences for primary outcome
for patients randomized to femoral access (high-volume
Table 4 Radial Versus Femoral Access by Radial PCI Operator Volume
Radial
(n ¼ 3,507)
Femoral
(n ¼ 3,514) HR (95% CI) p Value
Interaction
p Value
Primary outcome
High-volume operator 29 (2.5) 36 (3.1) 0.79 (0.48–1.28) 0.33 0.536
Intermediate-volume operator 50 (4.3) 57 (4.9) 0.87 (0.60–1.27) 0.48
Low-volume operator 49 (4.2) 46 (3.8) 1.10 (0.74–1.65) 0.63
Death, MI, or stroke
High-volume operator 24 (2.0) 31 (2.7) 0.76 (0.44–1.29) 0.30 0.453
Intermediate-volume operator 48 (4.2) 48 (4.2) 1.00 (0.67–1.49) 0.99
Low-volume operator 40 (3.4) 35 (2.9) 1.18 (0.75–1.86) 0.47
Death
High-volume operator 11 (0.9) 18 (1.6) 0.59 (0.28–1.26) 0.18 0.509
Intermediate-volume operator 19 (1.6) 19 (1.6) 1.00 (0.53–1.88) 1.00
Low-volume operator 14 (1.2) 14 (1.2) 1.03 (0.49–2.16) 0.94
MI
High-volume operator 13 (1.1) 12 (1.1) 1.06 (0.48–2.32) 0.89 0.762
Intermediate-volume operator 24 (2.1) 30 (2.6) 0.80 (0.47–1.36) 0.41
Low-volume operator 23 (2.0) 23 (1.9) 1.03 (0.58–1.84) 0.91
Stroke
High-volume operator 4 (0.3) 4 (0.4) 0.98 (0.25–3.93) 0.98 0.390
Intermediate-volume operator 9 (0.8) 8 (0.7) 1.12 (0.43–2.91) 0.81
Low-volume operator 7 (0.6) 2 (0.2) 3.66 (0.76–17.6) 0.11
Non-CABG major bleeding
High-volume operator 7 (0.6) 8 (0.7) 0.86 (0.31–2.36) 0.77 0.316
Intermediate-volume operator 5 (0.4) 13 (1.1) 0.38 (0.14–1.07) 0.07
Low-volume operator 12 (1.0) 12 (1.0) 1.04 (0.47–2.32) 0.92
ACUITY major bleeding
High-volume operator 15 (1.3) 54 (4.7) 0.27 (0.15–0.48) <0.001 0.110
Intermediate-volume operator 30 (2.6) 51 (4.4) 0.59 (0.37–0.92) 0.020
Low-volume operator 21 (1.8) 48 (4.0) 0.45 (0.27–0.75) 0.002
Major vascular complications
High-volume operator 10 (0.9) 49 (4.3) 0.20 (0.10–0.39) <0.001 0.009
Intermediate-volume operator 27 (2.3) 40 (3.5) 0.67 (0.41–1.10) 0.11
Low-volume operator 12 (1.0) 42 (3.5) 0.30 (0.16–0.56) <0.001
Access site crossover
High-volume operator 63 (5.3) 26 (2.3) 2.36 (1.49–3.73) <0.001 0.029
Intermediate-volume operator 104 (9.0) 27 (2.3) 3.87 (2.53–5.90) <0.001
Low-volume operator 97 (8.3) 17 (1.4) 5.97 (3.57–10.0) <0.001
PCI success rates
High-volume operator 851 (96.8) 813 (95.4) 1.02 (0.93–1.13) 0.66 0.876
Intermediate-volume operator 644 (93.7) 681 (95.0) 0.98 (0.88–1.10) 0.78
Low-volume operator 708 (95.6) 739 (95.2) 1.01 (0.91–1.12) 0.86
PCI complications
High-volume operator 16 (1.8) 21 (2.5) 0.74 (0.39–1.41) 0.36 0.649
Intermediate-volume operator 28 (4.1) 27 (3.8) 1.08 (0.64–1.83) 0.77
Low-volume operator 16 (2.2) 20 (2.6) 0.84 (0.43–1.62) 0.60
Values are n (%). High-volume operators enrolled 2,336 patients, intermediate-volume operators enrolled 2,315 patients, and low- volume operators
enrolled 2,363 patients.
MI ¼ myocardial infarction; other abbreviations as in Tables 1 and 3.
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959radial centers 3.2% vs. low-volume 4.2% for femoral
patients; adjusted HR: 0.67, 95% CI: 0.42 to 1.09;
p ¼ 0.10) and non-CABG major bleeding (adjusted HR:
1.07, 95% CI: 0.41 to 2.79; p ¼ 0.89).
Radial versus femoral access in subgroups of individual
operator volume (low, intermediate, and high). For the
primary outcome, there were no signiﬁcant differences
between radial and femoral access in the tertiles of high-(2.5% vs. 3.1%; HR: 0.79, 95% CI: 0.48 to 1.29), inter-
mediate- (4.3% vs. 4.9%; HR: 0.87, 95% CI: 0.60 to 1.27),
and low-volume radial operators (4.2% vs. 3.8%; HR: 1.10,
95% CI: 0.74 to 1.65; interaction p ¼ 0.54). There were no
signiﬁcant differences in the components of the primary
outcome between radial versus femoral access in the
subgroups of high-, intermediate-, and low-volume radial
operators (Table 4). There were signiﬁcant reductions in
Table 5 Outcome Stratiﬁed by STEMI and NSTEACS
N Radial Femoral HR (95% CI) p Value
Interaction
p Value
STEMI subgroup
Primary outcome
High-volume center 895 8 (1.8) 17 (3.8) 0.49 (0.21–1.13) 0.096 0.15
Intermediate-volume center 631 19 (6.3) 23 (7.0) 0.91 (0.50–1.68) 0.77
Low-volume center 432 3 (1.4) 12 (5.5) 0.25 (0.07–0.87) 0.030
High-volume operator 827 10 (2.5) 19 (4.5) 0.55 (0.25–1.17) 0.12 0.78
Intermediate-volume operator 591 15 (5.1) 21 (7.1) 0.71 (0.36–1.37) 0.31
Low-volume operator 538 5 (2.0) 12 (4.2) 0.47 (0.17–1.34) 0.16
Death
High-volume center 895 3 (0.7) 12 (2.7) 0.26 (0.07–0.92) 0.037 0.23
Intermediate-volume center 631 7 (2.3) 10 (3.0) 0.77 (0.29–2.02) 0.59
Low-volume center 432 2 (0.9) 10 (4.6) 0.20 (0.04–0.89) 0.035
High-volume operator 827 4 (1.0) 16 (3.8) 0.25 (0.08–0.76) 0.014 0.59
Intermediate-volume operator 591 5 (1.7) 9 (3.1) 0.54 (0.18–1.61) 0.27
Low-volume operator 538 3 (1.2) 7 (2.4) 0.49 (0.13–1.88) 0.30
Non-CABG major bleeding
High-volume center 895 2 (0.5) 5 (1.1) 0.43 (0.08–2.20) 0.31 0.42
Intermediate-volume center 631 4 (1.3) 3 (0.9) 1.48 (0.33–6.59) 0.61
Low-volume center 432 2 (0.9) 1 (0.5) 2.01 (0.18–22.2) 0.57
High-volume operator 827 2 (0.5) 3 (0.7) 0.73 (0.12–4.34) 0.73 0.92
Intermediate-volume operator 591 4 (1.4) 4 (1.4) 1.01 (0.24–4.04) 0.99
Low-volume operator 538 2 (0.8) 2 (0.7) 1.14 (0.16–8.11) 0.89
NSTEACS subgroup
Primary outcome
High-volume center 1,360 10 (1.5) 19 (2.8) 0.51 (0.24–1.10) 0.086 0.067
Intermediate-volume center 2,215 58 (5.2) 40 (3.7) 1.42 (0.95–2.13) 0.087
Low-volume center 1,488 30 (4.0) 28 (3.8) 1.07 (0.64–1.79) 0.80
Intermediate-volume operator 1,509 19 (2.5) 17 (2.3) 1.06 (0.55–2.04) 0.86 0.67
Low-volume operator 1,724 35 (4.1) 36 (4.2) 0.97 (0.61–1.55) 0.90
High-volume center 1,825 44 (4.8) 34 (3.7) 1.30 (0.83–2.03) 0.26
Death
High-volume center 1,360 6 (0.9) 5 (0.7) 1.15 (0.35–3.78) 0.82 0.80
Intermediate-volume center 2,215 16 (1.4) 9 (0.8) 1.74 (0.77–3.94) 0.18
Low-volume center 1,488 10 (1.3) 5 (0.7) 2.00 (0.68–5.84) 0.21
High-volume operator
Intermediate-volume operator 1,509 7 (0.9) 2 (0.3) 3.33 (0.69–16.0) 0.13 0.63
Low-volume operator 1,724 14 (1.6) 10 (1.2) 1.41 (0.63–3.17) 0.41
High-volume center 1,825 11 (1.2) 7 (0.8) 1.55 (0.60–3.99) 0.37
Non-CABG major bleeding
High-volume center 1,360 3 (0.4) 6 (0.9) 0.49 (0.12–1.95) 0.31 0.81
Intermediate-volume center 2,215 7 (0.6) 11 (1.0) 0.62 (0.24–1.60) 0.33
Low-volume center 1,488 6 (0.8) 7 (0.9) 0.86 (0.29–2.55) 0.78
High-volume operator 1,509 5 (0.7) 5 (0.7) 0.95 (0.27–3.28) 0.93 0.15
Intermediate-volume operator 1,724 1 (0.1) 9 (1.0) 0.11 (0.01–0.88) 0.038
Low-volume operator 1,825 10 (1.1) 10 (1.1) 1.02 (0.42–2.45) 0.97
Values are n (%).
Abbreviations as in Table 1.
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access within each of the tertiles of high-, intermediate-, and
low-volume radial operators (Table 4).
Beneﬁt of radial in high-volume centers persists after
adjustment for STEMI. High-volume centers enrolled
a much higher proportion of STEMI, and given the
interaction of both the STEMI and center subgroups, it
was important to determine the independent effect ofvolume after accounting for STEMI. After adjusting for
STEMI in the Cox proportional hazards model, the
beneﬁt of radial versus femoral access persisted in high-
volume radial centers (adjusted HR: 0.50, 95% CI: 0.28
to 0.88) compared with the intermediate- (HR: 1.24,
95% CI: 0.89 to 1.73) and low-volume radial centers
(adjusted HR: 0.83, 95% CI: 0.52 to 1.31; interaction
p ¼ 0.020). The results for center and operator tertiles
Figure 2 Center-Level Procedural Volume and Outcomes
Adjusted hazard ratio (HR) per 50 percutaneous coronary interventions (PCIs)/year for median operator at center. CABG ¼ coronary artery bypass graft; CI ¼ conﬁdence interval.
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Table 5 and show consistent ﬁndings for the primary
outcome.
PCIcenter volumeandoutcome (multivariableobservational
analysis). In a multivariable analysis, increasing PCI center
volume (per 50 PCI for median operator at center) was
independently associated with improved rates of primary
outcome (adjusted HR: 0.92, 95% CI: 0.88 to 0.96) (Fig. 2,
Online Table 1). Other independent predictors of the
primary outcome were age, serum creatinine level, systolic
blood pressure at presentation, STEMI at presentation,
Killip class II heart failure, and prior CABG surgery.
Similarly, in a multivariable analysis in only radial
patients, radial PCI center volume was also independently
associated with improved rates of primary outcome
(adjusted HR: 0.88, 95% CI: 0.80 to 0.97) (Fig. 2, Online
Table 2). Finally, in a multivariable analysis in only femoral
patients, femoral PCI center volume (adjusted HR: 1.00,
95% CI: 0.94 to 1.07) was not independently associated with
primary outcome (Fig. 2, Online Table 3).
For mortality, overall PCI center volume (HR: 0.94, 95%
CI: 0.88 to 1.01), radial volume (HR: 0.90, 95% CI: 0.77 to
1.04), or femoral volume (HR: 1.03, 95% CI: 0.92 to 1.14)
were not independently associated with overall mortality
(Fig. 2). For non-CABG major bleeding, overall PCI center
volume was independently associated with lower rates of
non-CABG major bleeding (HR: 0.82, 95% CI: 0.73 to
0.92), but this was not signiﬁcant for radial center volume(HR: 0.84, 95% CI: 0.64 to 1.10) or femoral center volume
(HR: 0.94, 95% CI: 0.81 to 1.09).
Individual PCI operator volume and outcome (multi-
variable analysis). In a multivariable analysis, using indi-
vidual PCI operator volume as a continuous variable,
increasing overall PCI (radial þ femoral) operator volume
(per 50 PCI) was independently associated with improved
rates of the primary outcome (adjusted HR: 0.94, 95% CI:
0.90 to 0.97) (Fig. 3). Similarly, in a multivariable analysis
in only radial patients, radial operator volume was also
independently associated with primary outcome (adjusted
HR: 0.90, 95% CI: 0.83 to 0.98) (Fig. 3). In femoral
patients, femoral operator volume (adjusted HR: 1.00, 95%
CI: 0.94 to 1.07) was not independently associated with
primary outcome (Fig. 3).
Discussion
RIVAL is the largest trial to compare radial versus femoral
access among patients with acute coronary syndromes. In
high-volume radial centers, radial access signiﬁcantly
reduced the primary outcome compared with femoral access,
but this was not observed in intermediate- or low-volume
radial centers. By contrast, we found no interaction accor-
ding to individual operator radial volume. At the level of
both center and operator, overall PCI volume and radial
volume were independently associated with the primary
outcome, but not femoral volume.
Figure 3 Operator-Level Procedural Volume and Outcomes
Adjusted HR per 50 PCIs/year for individual operator. Abbreviations as in Figure 2.
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center volume to be a more robust predictor of outcome
compared to individual operator volume (2,8). The stronger
relationship with center volume and outcome in the litera-
ture may provide insight into our ﬁndings of a signiﬁcant
subgroup interaction at the center level but not operator
level for radial access (7). In an analysis of the New York
Registry (N ¼ 107,713), after adjustment for case mix,
mortality after PCI was only associated with center volume
and not operator volume (8). Similarly, in an analysis from
the Medicare National Claims Database (N ¼ 167,208),
after adjustment, mortality was only associated with center
volume and not operator volume (2). It is possible that the
center effect is greater due to the care of the whole team of
healthcare providers (interventional fellows and nurses) and
center resources rather than just the individual senior
physician.
Finally, is it possible the beneﬁt observed in high-volume
radial centers is due to their lack of expertise with femoral
access and worse femoral outcomes? This hypothesis is not
supported by the data in the RIVAL trial; the primary
outcome rates trended lower among femoral cases in high-
volume radial centers compared with low-volume radial
centers, which were primarily femoral centers (3.8% vs. 4.2%,
respectively) with similar rates of non-CABGmajor bleeding.
Prior studies in predominantly femoral PCI have
demonstrated improved outcomes in operators performing
more than 50 PCI procedures per year (2). The lack of
a relationship between femoral PCI volume and outcomein the RIVAL study may be due to the fact that the
procedural volume range in RIVAL was much higher than
most prior studies (median PCI volume of 300/year/oper-
ator; interquartile range: 190 to 400) so that the level of
experience for femoral procedures was high enough in all
centers, such that they were all similarly expert.
Study limitations. First, lifetime experience of radial access
of operators at our centers was not captured in the RIVAL
study. It is possible that senior individuals performing radial
access for many years may have a different annual volume
outcome relationship than individuals with less experience.
Second, the involvement of trainees during procedures was
not recorded and it is possible that larger, higher-volume
centers may have more trainees involved in procedures.
Third, subgroup ﬁndings should generally be considered
exploratory despite being pre-speciﬁed and consistent with
pre-speciﬁed direction. Fourth, procedural volume may be
an imperfect surrogate for expertise as some operators may
require different annual volume to achieve the same proﬁ-
ciency. Fifth, lifetime procedural volume was not collected
in RIVAL so we cannot identify a minimum of procedures
for proﬁciency. Finally, the association between procedural
volume and outcome may not be causal as there may be
other variables that impact outcomes at these institutions.
Conclusions
In the RIVAL trial, radial access compared with femoral
access reduced the primary outcome in high-volume radial
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963centers. Increasing procedural volume was independently
associated with better outcomes particularly with radial
access.
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